Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Obesity HELP
Based on 100,000 articles published since 2009
|||| 27 

These are the 100000 published articles about Obesity that originated from Worldwide during 2009-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. 2019

Elmets, Craig A / Leonardi, Craig L / Davis, Dawn M R / Gelfand, Joel M / Lichten, Jason / Mehta, Nehal N / Armstrong, April W / Connor, Cody / Cordoro, Kelly M / Elewski, Boni E / Gordon, Kenneth B / Gottlieb, Alice B / Kaplan, Daniel H / Kavanaugh, Arthur / Kivelevitch, Dario / Kiselica, Matthew / Korman, Neil J / Kroshinsky, Daniela / Lebwohl, Mark / Lim, Henry W / Paller, Amy S / Parra, Sylvia L / Pathy, Arun L / Prater, Elizabeth Farley / Rupani, Reena / Siegel, Michael / Stoff, Benjamin / Strober, Bruce E / Wong, Emily B / Wu, Jashin J / Hariharan, Vidhya / Menter, Alan. ·University of Alabama, Birmingham, Alabama. · Central Dermatology, St. Louis, Missouri. · Mayo Clinic, Rochester, Minnesota. · University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. · National Psoriasis Foundation, Portland, Oregon. · National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland. · University of Southern California, Los Angeles, California. · Department of Dermatology, University of California San Francisco School of MedicineSan Francisco, California. · Medical College of Wisconsin, Milwaukee, Wisconsin. · Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York, New York. · University of Pittsburgh, Pennsylvania. · University of California San Diego, San Diego, California. · Baylor Scott and White, Dallas, Texas. · University Hospitals Cleveland Medical Center, Cleveland, Ohio. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Dermatology, Henry Ford Hospital, Detroit, Michigan. · Northwestern University Feinberg School of Medicine, Chicago, Illinois. · Dermatology and Skin Surgery, Sumter, South Carolina. · Colorado Permanente Medical Group, Centennial, Colorado. · University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. · Icahn School of Medicine at Mount Sinai, New York, New York. · Emory University School of Medicine, Atlanta, Georgia. · University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Canada. · San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas. · Dermatology Research and Education Foundation, Irvine, California. · American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org. ·J Am Acad Dermatol · Pubmed #30772097.

ABSTRACT: Psoriasis is a chronic, inflammatory, multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations on the basis of available evidence.

2 Guideline Care of Women with Obesity in Pregnancy: Green-top Guideline No. 72. 2019

Denison, F C / Aedla, N R / Keag, O / Hor, K / Reynolds, R M / Milne, A / Diamond, A / Anonymous1491094. · ·BJOG · Pubmed #30465332.

ABSTRACT: -- No abstract --

3 Guideline [Consensus statement of the Chilean endocrinological society on the role of bariatric surgery in type 2 diabetes]. 2018

Sapunar, Jorge / Escalona, Alex / Araya, A Verónica / Aylwin, Carmen Gloria / Bastías, María Juliana / Boza, Camilo / Cárcamo, Carlos / Csendes A, Attila / Davidof F, Patricio / Funke, Ricardo / Gómez, Patricia / González, María Isabel / Lahsen, Rodolfo / Lanzarini, Enrique / Maíz, Alberto / Mujica, Verónica / Muñoz, Rodrigo / Pérez, Gustavo / Raimann, Félix / Salman, Patricio / Sepúlveda, Matías / Soto, Néstor / Villagrán, Rodrigo. ·Departamento de Medicina Interna y Centro EPICYN, Facultad de Medicina, Universidad de la Frontera, Temuco, Chile. · Clínica Universidad de los Andes, Facultad de Medicina, Universidad de los Andes, Santiago, Chile. · Hospital Clínico, Universidad de Chile, Santiago, Chile. · Sección Endocrinología, Diabetes y Nutrición, Departamento de Medicina Interna, Hospital Naval Almirante Nef, Viña del Mar, Chile. · Clínica Las Condes, Santiago, Chile. · Instituto de Cirugía, Facultad de Medicina, Universidad Austral de Chile, Valdivia, Chile. · Hospital FACH, Santiago, Chile. · Clínica Sanatorio Alemán, Concepción, Chile. · Departamento. Nutrición, Diabetes y Metabolismo, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. · Facultad de Medicina, Universidad Católica del Maule, Talca, Chile. · Departamento de Cirugía Digestiva, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. · Centro Integral de Obesidad y Diabetes, Servicio de Cirugía y Endoscopía, Clínica Puerto Varas, Puerto Varas, Chile. · Unidad de Endocrinología, Departamento de Medicina Interna, Facultad de Medicina. universidad de Concepción. Concepción, Chile. · Hospital de la Dirección de Previsión de Carabineros de Chile (DIPRECA). Santiago, Chile. · Unidad de Endocrinología y Diabetes, Servicio de Medicina Interna, Hospital San Borja Arriarán. Santiago, Chile. · Departamento de Cirugía Bariátrica Metabólica, Clínica Bupa Antofagasta. Antofagasta, Chile. ·Rev Med Chil · Pubmed #30724982.

ABSTRACT: Diabetes Mellitus (DM) and obesity are a public health problem in Chile. Bariatric surgery is the most effective treatment alternative to achieve a significant and sustained weight reduction in patients with morbid obesity. The results of controlled clinical trials indicate that, compared to medical treatment, surgery for obese patients with DM2 allows a better control of blood glucose and cardiovascular risk factors, reduces the need for medications and increases the likelihood for remission. Consensus conferences and clinical practice guidelines support bariatric surgery as an option to treat DM2 in Class III Obesity (Body Mass Index (BMI) > 40) regardless of the glycemic control and the complexity of pharmacological treatment and in Class II Obesity (BMI 35-39,9) with inadequate glycemic control despite optimal pharmacological treatment and lifestyle. However, surgical indication for patients with DM2 and BMI between 30-34.9, the most prevalent sub-group, is only suggested. The Chilean Societies of Endocrinology and Diabetes and of Bariatric and Metabolic Surgery decided to generate a consensus regarding the importance of other factors related to DM2 that would allow a better selection of candidates for surgery, particularly when weight does not constitute an indication. Considering the national reality, we also need a statement regarding the selection and characteristics of the surgical procedure as well as the role of the diabetologist in the multidisciplinary team.

4 Guideline [Childbirth pelvic floor trauma: Anatomy, physiology, pathophysiology and special situations - CNGOF perineal prevention and protection in obstetrics guidelines]. 2018

de Tayrac, R / Schantz, C. ·Service de gynécologie-obstétrique, CHU Carémeau, place du Pr-Debré, 30900 Nîmes, France. Electronic address: renaud.detayrac@chu-nimes.fr. · Commission Scientifique du Collège National des Sages-Femmes (CNSF), Centre population et développement (Ceped), institut de la recherche et du développement (IRD), université Paris Descartes, Inserm, 75006, Paris, France. ·Gynecol Obstet Fertil Senol · Pubmed #30396762.

ABSTRACT: OBJECTIVES: To assess whether pelvic size and shape, spinal curvature, perineal body length and genital hiatus size are associated with the incidence of childbirth pelvic floor trauma. Special situations, such as obesity, ethnicity and hyperlaxity, will also be studied. METHODS: A bibliographic research using Pubmed and Cochrane Library databases was conducted until May 2018. Publications in English and French were selected by initial reading of the abstracts. Randomized trials, meta-analyzes, case-control studies and large cohorts were studied in a privileged way. RESULTS: A pubic arch angle<90° (measured clinically) does not appear to increase the risk of OASIS (Level 3), but appears to be a risk factor for postnatal anal incontinence at short-term, but not at long-term (Level 3). Measurement of pelvic dimensions and the subpubic angle is not recommended to predict OASIS or to choose the mode of delivery for the purpose of protecting the perineum (GradeC). Prenatal measurement of both perineal body (Level 3) and genital hiatus (Level 2) does not predict the incidence of 2nd or 3rd degree OASIS. Therefore, the routine prenatal measurement of the length of the perineal body or the genital hiatus is not recommended for any objective related to perineal protection (Grade C). Levator avulsion, resulting in a widening of the genital hiatus, is potentially a source of long-term pelvic floor dysfunction. Biomechanical models suggest that performing a mediolateral episiotomy and applying the fingers to the posterior perineum at the time of expulsive phase may reduce pelvic floor trauma. Obese women have a longer perineal body (Level 3), and obesity does not seem to increase the risk of OASIS (Level 2). There is no difference between Asian and non-Asian women perineal body (Level 3). No studies have validated that the liberal practice of episiotomy in Asian women reduced the risk of OASIS. It is therefore not recommended to practice an episiotomy for simple ethnic reasons in Asian women (GradeC). Compared to white women, black women do not appear to have an increased risk of OASIS and even appear to have a decreased risk of perineal tears of all stages (Level 2). Ligament hyperlaxity seems to be associated with an increased risk of OASIS (Level 2). CONCLUSIONS: Prenatal assessment of pelvis bone, spine curvature, perineal body and genital hiatus do not allow to predict the incidence of childbirth pelvic floor trauma. Obesity and ethnicity are not risk factors for OASIS.

5 Guideline 2019 Canadian guideline for physical activity throughout pregnancy. 2018

Mottola, Michelle F / Davenport, Margie H / Ruchat, Stephanie-May / Davies, Gregory A / Poitras, Veronica J / Gray, Casey E / Jaramillo Garcia, Alejandra / Barrowman, Nick / Adamo, Kristi B / Duggan, Mary / Barakat, Ruben / Chilibeck, Phil / Fleming, Karen / Forte, Milena / Korolnek, Jillian / Nagpal, Taniya / Slater, Linda G / Stirling, Deanna / Zehr, Lori. ·R Samuel McLaughlin Foundation-Exercise and Pregnancy Laboratory, School of Kinesiology, Faculty of Health Sciences, Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Children's Health Research Institute, The University of Western Ontario, London, Ontario, Canada. · Program for Pregnancy and Postpartum Health, Faculty of Kinesiology, Sport and Recreation, Women and Children's Health Research Institute, Alberta Diabetes Institute, University of Alberta, Edmonton, Alberta, Canada. · Department of Human Kinetics, Universite du Quebec a Trois-Rivieres, Trois-Rivieres, Quebec, Canada. · Department of Obstetrics and Gynecology, Queen's University, Kingston, Ontario, Canada. · Independent Researcher, Ottawa, Ontario, Canada. · Healthy Active Living and Obesity Research Group, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. · Clinical Research Unit, Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada. · School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada. · Canadian Society for Exercise Physiology, Ottawa, Ontario, Canada. · Facultad de Ciencias de la Actividad Física y del Deporte-INEF, Universidad Politécnica de Madrid, Madrid, Spain. · College of Kinesiology, University of Saskatchewan, Saskatoon, Canada. · Department of Family and Community Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. · Department of Family and Community Medicine, University of Toronto, Granovsky Gluskin Family Medicine Centre, Sinai Health System, Sinai Health System, Toronto, Ontario, Canada. · Canadian Association of Midwives, Toronto, Canada. · John W Scott Health Sciences Library, University of Alberta, Edmonton, Alberta, Canada. · Middlesex-London Health Unit, London, Ontario, Canada. · School of Health and Human Services, Camosun College, Victoria, Canada. ·Br J Sports Med · Pubmed #30337460.

ABSTRACT: The objective is to provide guidance for pregnant women and obstetric care and exercise professionals on prenatal physical activity. The outcomes evaluated were maternal, fetal or neonatal morbidity, or fetal mortality during and following pregnancy. Literature was retrieved through searches of MEDLINE, EMBASE, PsycINFO, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Scopus and Web of Science Core Collection, CINAHL Plus with Full Text, Child Development & Adolescent Studies, Education Resources Information Center, SPORTDiscus, ClinicalTrials.gov and the Trip Database from inception up to 6 January 2017. Primary studies of any design were eligible, except case studies. Results were limited to English-language, Spanish-language or French-language materials. Articles related to maternal physical activity during pregnancy reporting on maternal, fetal or neonatal morbidity, or fetal mortality were eligible for inclusion. The quality of evidence was rated using the Grading of Recommendations Assessment, Development and Evaluation methodology. The Guidelines Consensus Panel solicited feedback from end users (obstetric care providers, exercise professionals, researchers, policy organisations, and pregnant and postpartum women). The development of these guidelines followed the Appraisal of Guidelines for Research and Evaluation II instrument. The benefits of prenatal physical activity are moderate and no harms were identified; therefore, the difference between desirable and undesirable consequences (net benefit) is expected to be moderate. The majority of stakeholders and end users indicated that following these recommendations would be feasible, acceptable and equitable. Following these recommendations is likely to require minimal resources from both individual and health systems perspectives.

6 Guideline Behavioral Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: US Preventive Services Task Force Recommendation Statement. 2018

Anonymous2681258 / Curry, Susan J / Krist, Alex H / Owens, Douglas K / Barry, Michael J / Caughey, Aaron B / Davidson, Karina W / Doubeni, Chyke A / Epling, John W / Grossman, David C / Kemper, Alex R / Kubik, Martha / Landefeld, C Seth / Mangione, Carol M / Phipps, Maureen G / Silverstein, Michael / Simon, Melissa A / Tseng, Chien-Wen / Wong, John B. ·University of Iowa, Iowa City. · Fairfax Family Practice Residency, Fairfax, Virginia. · Virginia Commonwealth University, Richmond. · Veterans Affairs Palo Alto Health Care System, Palo Alto, California. · Stanford University, Stanford, California. · Harvard Medical School, Boston, Massachusetts. · Oregon Health & Science University, Portland. · Columbia University, New York, New York. · University of Pennsylvania, Philadelphia. · Virginia Tech Carilion School of Medicine, Roanoke. · Kaiser Permanente Washington Health Research Institute, Seattle. · Nationwide Children's Hospital, Columbus, Ohio. · Temple University, Philadelphia, Pennsylvania. · University of Alabama at Birmingham. · University of California, Los Angeles. · Brown University, Providence, Rhode Island. · Boston University, Boston, Massachusetts. · Northwestern University, Evanston, Illinois. · University of Hawaii, Honolulu. · Pacific Health Research and Education Institute, Honolulu, Hawaii. · Tufts University, Medford, Massachusetts. ·JAMA · Pubmed #30326502.

ABSTRACT: Importance: More than 35% of men and 40% of women in the United States are obese. Obesity is associated with health problems such as increased risk for coronary heart disease, type 2 diabetes, various types of cancer, gallstones, and disability. Obesity is also associated with an increased risk for death, particularly among adults younger than 65 years. Objective: To update the US Preventive Services Task Force (USPSTF) 2012 recommendation on screening for obesity in adults. Evidence Review: The USPSTF reviewed the evidence on interventions (behavioral and pharmacotherapy) for weight loss or weight loss maintenance that can be provided in or referred from a primary care setting. Surgical weight loss interventions and nonsurgical weight loss devices (eg, gastric balloons) are considered to be outside the scope of the primary care setting. Findings: The USPSTF found adequate evidence that intensive, multicomponent behavioral interventions in adults with obesity can lead to clinically significant improvements in weight status and reduce the incidence of type 2 diabetes among adults with obesity and elevated plasma glucose levels; these interventions are of moderate benefit. The USPSTF found adequate evidence that behavior-based weight loss maintenance interventions are of moderate benefit. The USPSTF found adequate evidence that the harms of intensive, multicomponent behavioral interventions (including weight loss maintenance interventions) in adults with obesity are small to none. Therefore, the USPSTF concludes with moderate certainty that offering or referring adults with obesity to intensive behavioral interventions or behavior-based weight loss maintenance interventions has a moderate net benefit. Conclusions and Recommendation: The USPSTF recommends that clinicians offer or refer adults with a body mass index of 30 or higher to intensive, multicomponent behavioral interventions. (B recommendation).

7 Guideline Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). 2018

Davies, Melanie J / D'Alessio, David A / Fradkin, Judith / Kernan, Walter N / Mathieu, Chantal / Mingrone, Geltrude / Rossing, Peter / Tsapas, Apostolos / Wexler, Deborah J / Buse, John B. ·Diabetes Research Centre, University of Leicester, Leicester, U.K. · Leicester Diabetes Centre, Leicester General Hospital, Leicester, U.K. · Department of Medicine, Duke University School of Medicine, Durham, NC. · National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD. · Department of Medicine, Yale School of Medicine, New Haven, CT. · Clinical and Experimental Endocrinology, UZ Gasthuisberg, KU Leuven, Leuven, Belgium. · Department of Internal Medicine, Catholic University, Rome, Italy. · Diabetes and Nutritional Sciences, King's College London, London, U.K. · Steno Diabetes Center Copenhagen, Gentofte, Denmark. · University of Copenhagen, Copenhagen, Denmark. · Second Medical Department, Aristotle University Thessaloniki, Thessaloniki, Greece. · Department of Medicine and Diabetes Unit, Massachusetts General Hospital, Boston, MA. · Harvard Medical School, Boston, MA. · Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC jbuse@med.unc.edu. ·Diabetes Care · Pubmed #30291106.

ABSTRACT: The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the prior position statements, published in 2012 and 2015, on the management of type 2 diabetes in adults. A systematic evaluation of the literature since 2014 informed new recommendations. These include additional focus on lifestyle management and diabetes self-management education and support. For those with obesity, efforts targeting weight loss, including lifestyle, medication, and surgical interventions, are recommended. With regards to medication management, for patients with clinical cardiovascular disease, a sodium-glucose cotransporter 2 (SGLT2) inhibitor or a glucagon-like peptide 1 (GLP-1) receptor agonist with proven cardiovascular benefit is recommended. For patients with chronic kidney disease or clinical heart failure and atherosclerotic cardiovascular disease, an SGLT2 inhibitor with proven benefit is recommended. GLP-1 receptor agonists are generally recommended as the first injectable medication.

8 Guideline Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology. 2018

Góralska, Magdalena / Bednarczuk, Tomasz / Rosłon, Marek / Libura, Maria / Szalecki, Mieczysław / Hilczer, Maciej / Stawerska, Renata / Smyczyńska, Joanna / Karbownik-Lewińska, Małgorzata / Walczak, Mieczysław / Lewiński, Andrzej. ·alewin@csk.umed.lodz.pl. ·Endokrynol Pol · Pubmed #30209801.

ABSTRACT: Prader-Willi syndrome (PWS) is a complex genetic disorder characterised by a set of phenotypic traits, which include infantile hypotonia, short stature, and morbid obesity. Over the last 12 years, visible progress has been made in medical care management of PWS patients in Poland. Increasing awareness of the disorder in neonatal and paediatric care has led to early identification of the condition in neonates, followed by the institution of an appropriate dietary regime, introduction of physiotherapy, and early-onset recombinant human growth hormone (rhGH) treatment. Growth hormone (GH) therapy in Poland is conducted within the nationwide framework of the Therapeutic Programme: "Treatment of Prader-Willi Syndrome". The therapeutic interventions initiated in the paediatric centres need to be continued in multidisciplinary adult care settings. The main aim of PWS clinical management in adulthood is prevention of obesity and its comor-bidities, treatment of hormonal disorders, mental health stabilisation, nutritional guidance, as well as on-going physiotherapy. Integrated multidisciplinary therapeutic intervention is necessary if patients with such a complex genetic condition as PWS are to not only achieve an average life expectancy but also to enjoy higher quality of life.

9 Guideline American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. 2018

Menzo, Emanuele Lo / Hinojosa, Marcelo / Carbonell, Alfredo / Krpata, David / Carter, Jonathan / Rogers, Ann M. ·Section of Minimally Invasive and Endoscopic Surgery, Cleveland Clinic Florida, The Bariatric and Metabolic Institute, Weston, Florida. · Department of Surgery, University of California, Irvine Medical Center, Irvine, California. · Department of Surgery, Division of Minimal Access and Bariatric Surgery, Greenville Health System, University of South Carolina School of Medicine, Greenville, South Carolina. · Comprehensive Hernia Center, Digestive Disease and Surgical Institute, The Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Surgery, University of California-San Francisco, San Francisco, California. · Department of Surgery, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania. Electronic address: arogers@pennstatehealth.psu.edu. ·Surg Obes Relat Dis · Pubmed #30154033.

ABSTRACT: The American Society for Metabolic and Bariatric Surgery issues the following guidelines for the purpose of enhancing quality of care in hernia treatment through metabolic and bariatric surgery. In this statement, suggestions for management are presented that are derived from available knowledge, peer-reviewed scientific literature, and expert opinion. This was accomplished by performing a review of currently available literature regarding obesity, obesity treatments, and hernia surgery. The intent of issuing such a guideline is to provide objective information regarding the impact of obesity treatment on effective and durable hernia repair. The guideline may be revised in the future should additional evidence become available.

10 Guideline Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. 2018

Espinet Coll, Eduardo / López-Nava Breviere, Gontrand / Nebreda Durán, Javier / Marra-López Valenciano, Carlos / Turró Arau, Román / Esteban López-Jamar, José Miguel / Muñoz-Navas, Miguel. ·Aparato Digestivo, Gastrodex. Hospital Universitario Quiron Dexeus, España. · Hospital Universitario Madrid Sanchinarro, España. · Clínica Diagonal, España. · Complejo Hospitalario de Navarra, España. · Hospital Quirón Teknon. · Endoscopia, Hospital Clinico San Carlos, SPAIN. · Aparato Digestivo, Clínica Universidad de Navarra. ·Rev Esp Enferm Dig · Pubmed #29766736.

ABSTRACT: Obesity is a chronic multifactorial, incurable, recurrent, and progressive disease associated with significant physical and psychological complications, and considerable morbidity and mortality. For this reason, the assessment, management, and follow-up of obese patients should take place in the setting of a multidisciplinary unit equipped with adequate human and structural resources. Medical treatment using hygienic-dietary measures, while indispensable, may be insufficient, and surgery, which is reserved for severe or morbid obesity, is not exempt from complications neither is to the liking of many patients. In this context three situations may be considered where endoscopic treatment, used as a supplementary strategy with few complications, contributes to benefit obese patients: first, in a subgroup of patients with grade-II overweight or non-morbid obesity where medical therapy alone failed or needs supplementation. Second, in patients with morbid obesity when surgery is rejected, is contraindicated, or entails excessive risk. Finally, in patients with superobesity who need to lose weight before bariatric surgery in order to reduce surgery-related morbidity and mortality. In this regard, the Spanish Task Force on Bariatric Endoscopy (Grupo Español de Trabajo para el Tratamiento Endoscópico del Metabolismo y la Obesidad, GETTEMO) have developed this Consensus Document to serve as practical guidance for all professionals involved in the endoscopic management of obesity, and to facilitate establishing a minimum set of requirements for the proper functioning of a bariatric endoscopy unit.

11 Guideline Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment. 2018

Kotsis, Vasilios / Jordan, Jens / Micic, Dragan / Finer, Nicholas / Leitner, Deborah R / Toplak, Hermann / Tokgozoglu, Lale / Athyros, Vasilios / Elisaf, Moses / Filippatos, Theodosios D / Redon, Josep / Redon, Pau / Antza, Christina / Tsioufis, Konstantinos / Grassi, Guido / Seravalle, Gino / Coca, Antonio / Sierra, Cristina / Lurbe, Empar / Stabouli, Stella / Jelakovic, Bojan / Nilsson, Peter M. ·3rd Department of Internal Medicine, Hypertension-24 h ABPM ESH Center of Excellence, Papageorgiou Hospital, Aristotle University of Thessaloniki, Greece. · Institute for Clinical Pharmacology, Medical School Hannover, Hannover, Germany. · Center for Obesity, Clinic for Endocrinology, Diabetes and Diseases of Metabolism Clinical Center of Serbia, Serbia. · National Centre for Cardiovascular Prevention and Outcomes, UCL Institute of Cardiovascular Science, London, UK. · Department of Medicine, Medical University Graz, Graz, Austria. · Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. · Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki. · Department of Internal Medicine, School of Medicine, University of Ioannina, Ioannina. · Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Crete, Greece. · INCLIVA Research Institute, University of Valencia, Valencia. · CIBERObn (CB06/03), Instituto de Salud Carlos III, Madrid, Spain. · First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens Hippokration Hospital, Athens, Greece. · Clinica Medica,School of Medicine and Surgery, Milano-Bicocca University. · IRCCS, Multimedica Sesto San Giovanni. · Cardiology Department Istituto Auxologico Italiano, S. Luca Hospital, Milan, Italy. · Hypertension and Vascular Risk Unit, Department of Internal Medicine, Hospital Clínic of Barcelona (IDIBAPS), University of Barcelona. · Pediatric Department, Consorcio Hospital General, University of Valencia, Valencia. · CIBERObn (CB06/03) Instituto de Salud Carlos III, Madrid, Spain. · 1st Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece. · Department of Nephrology, Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb,Croatia. · Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden. ·J Hypertens · Pubmed #29634663.

ABSTRACT: : Obesity is a key factor for cardiovascular diseases and complications. Obesity is associated with hypertension, dyslipidemia and type II diabetes, which are the major predictors of cardiovascular disease in the future. It predisposes for atrial fibrillation, heart failure, sudden cardiac death, renal disease and ischemic stroke that are the main causes of cardiovascular hospitalization and mortality. As obesity and the cardiovascular effects on the vessels and the heart start early in life, even from childhood, it is important for health policies to prevent obesity very early before the disease manifestation emerge. Key roles in the prevention are strategies to increase physical exercise, reduce body weight and to prevent or treat hypertension, lipids disorders and diabetes earlier and efficiently to prevent cardiovascular complications.Epidemiology and mechanisms of obesity-induced hypertension, diabetes and dyslipidemia will be reviewed and the role of lifestyle modification and treatment strategies in obesity will be updated and analyzed. The best treatment options for people with obesity, hypertension, diabetes and dyslipidemia will discussed.

12 Guideline The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. 2018

Chalasani, Naga / Younossi, Zobair / Lavine, Joel E / Charlton, Michael / Cusi, Kenneth / Rinella, Mary / Harrison, Stephen A / Brunt, Elizabeth M / Sanyal, Arun J. ·Indiana University School of Medicine, Indianapolis, IN. · Center for Liver Disease and Department of Medicine, Inova Fairfax Hospital, Falls Church, VA. · Columbia University, New York, NY. · University of Chicago, Chicago, IL. · University of Florida, Gainesville, FL. · Northwestern University, Chicago, IL. · Pinnacle Clinical Research, San Antonio, TX. · Washington University School of Medicine, St. Louis, MO. · Virginia Commonwealth University, Richmond, VA. ·Hepatology · Pubmed #28714183.

ABSTRACT: -- No abstract --

13 Guideline [Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]. 2017

Simon, Nicolas / Coiteux, Valérie / Bruno, Bénédicte / Taque, Sophie / Charbonnier, Amandine / Souchet, Laetitia / Vincent, Laure / Yakoub-Agha, Ibrahim / Chalandon, Yves. ·Université de Lille, EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, 59000 Lille, France; CHU de Lille, institut de pharmacie, 59000 Lille, France. · CHU de Lille, service des maladies du sang, 59000 Lille, France. · CHU de Lille, service d'hématologie pédiatrique, 59000 Lille, France. · CHU Anne de Bretagne, service d'hémato-oncologie pédiatrique, 2, rue Henri-Le- Guilloux, 35033 Rennes cedex 9, France. · CHU, service d'hématologie clinique et de thérapie cellulaire, 80054 Amiens cedex 1, France. · Groupe hospitalier Pitié-Salpêtrière, service d'hématologie clinique, 47-83, boulevard de l'Hôpital, 75013 Paris, France. · CHU, département d'hématologie clinique, 191, avenue du Doyen-Gaston-Giraud, 34295 Montpellier, France. · CHU de Lille, LIRIC Inserm U995, université de Lille 2, 59000 Lille, France. Electronic address: Ibrahim.YAKOUBAGHA@CHRU-LILLE.FR. · Hôpitaux universitaires de Genève et faculté de médecine université de Genève, service d'hématologie, 4, rue Gabrielle-Perret-Gentil, 1205 Genève, Suisse. ·Bull Cancer · Pubmed #29173979.

ABSTRACT: In September 2016 in Lille, France, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organized the 7th Allogeneic Stem Cell Transplantation Clinical Practices Harmonization Workshop Series. Our work group focused on chemotherapy drug dose adaptation for hematopoietic stem cell transplantation patients presenting a comorbidity. The purpose of this workshop was to provide recommendations on chemotherapy drug dose adaptation for patient populations receiving hematopoietic stem cell transplantation who also had the following comorbidities: obesity, chronic kidney disease and hepatopathy.

14 Guideline Committee Opinion No. 714: Obesity in Adolescents. 2017

Anonymous580917. · ·Obstet Gynecol · Pubmed #28832485.

ABSTRACT: Rates of obesity among adolescents in the United States have increased at a dramatic rate along with the prevalence of weight-related diseases. Between the 1980s and 2014, the prevalence of obesity among adolescent females in the United States increased from approximately 10% to 21%. Although the steep increase in the prevalence of obesity in children (2-11 years) has slowed, the prevalence of obesity in adolescents (12-19 years) continues to increase. Because the obese female adolescent faces medical, psychologic, and reproductive health challenges, early intervention is imperative in preventing short-term and long-term morbidity. The obstetrician-gynecologist who is knowledgeable about the behavioral and environmental factors that influence obesity may be better able to educate parents, guardians, and adolescents and advocate for programs that increase physical activity and improve nutrition. The obstetrician-gynecologist should be able to identify obese adolescents, particularly those at risk of comorbid conditions. They may have the opportunity to initiate behavioral counseling, participate in multidisciplinary teams that care for overweight and obese adolescents, and advocate for community programs to prevent obesity.

15 Guideline Committee Opinion No. 714 Summary: Obesity in Adolescents. 2017

Anonymous500917. · ·Obstet Gynecol · Pubmed #28832476.

ABSTRACT: Rates of obesity among adolescents in the United States have increased at a dramatic rate along with the prevalence of weight-related diseases. Between the 1980s and 2014, the prevalence of obesity among adolescent females in the United States increased from approximately 10% to 21%. Although the steep increase in the prevalence of obesity in children (2-11 years) has slowed, the prevalence of obesity in adolescents (12-19 years) continues to increase. Because the obese female adolescent faces medical, psychologic, and reproductive health challenges, early intervention is imperative in preventing short-term and long-term morbidity. The obstetrician-gynecologist who is knowledgeable about the behavioral and environmental factors that influence obesity may be better able to educate parents, guardians, and adolescents and advocate for programs that increase physical activity and improve nutrition. The obstetrician-gynecologist should be able to identify obese adolescents, particularly those at risk of comorbid conditions. They may have the opportunity to initiate behavioral counseling, participate in multidisciplinary teams that care for overweight and obese adolescents, and advocate for community programs to prevent obesity.

16 Guideline Indian College of Physicians Position Statement on Anemia in Metabolic Syndrome. 2017

Sahay, Manisha / Kalra, Sanjay / Tiwaskar, Mangesh / Ghosh, Sujoy / Badani, Rajesh / Bantwal, Ganapathi / Das, A K / Dhorepatil, Bharti / Jeloka, Tarun / Khandelwal, Deepak / Nadkar, Milind Y / Saboo, Banshi / Sahay, Rakesh / Unnikrishnan, A G / Aggarwal, Sameer / Agrawal, Navneet / Bajaj, Sarita / Baruah, Manash P / Chadha, Manoj / Das, Sambit / Dhamija, Puneet / Julka, Sandeep / Mehta, Prashant / Shah, Siddharth N / Sharma, Balram / Muruganathan, A. ·Osmania Medical college, Hyderabad, Telangana. · Bharti Hospital, Karnal, Haryana. · Asian Heart Institute and Research Centre, Mumbai, Maharashtra. · IGPGMER, Kolkata, West Bengal. · Aditya Birla Memorial Hospital, Pune, Maharashtra. · St Johns Medical College and Hospital, Bengaluru, Karnataka. · Pondicherry Institute of Medical Sciences, Puducherry. · Shree Hospital, Pune, Maharashtra. · Maharaja Agrasen Hospital, Punjabi Bagh, Delhi. · Seth G.S. Medical College and KEM Hospital, Mumbai, Maharashtra. · Dia Care - Diabetes Care and Hormone Clinic, Ambawadi, Ahmedabad, Gujarat. · Chellaram Diabetes Institute, Pune, Maharashtra. · Post Graduate Institute of Medical Sciences, Rohtak, Haryana. · Diabetes Obesity and Thyroid Centre, Gwalior, Madhya Pradesh. · MLN Medical College, Allahabad, India. · Excel Centre Hospitals, Guwahati, Assam. · Hinduja Hospital, Mumbai, Maharashtra. · Apollo Hospitals, Bhubaneshwar, Orissa. · AIIMS, Rishikesh, Uttarakhand. · Radiance - The Hormone Health Clinic, Indore, Madhya Pradesh. · Asian Hospital, Faridabad, Haryana. · Bhatia Hospital, Tardeo. · SMS Medical College and Hospital, Jaipur, Rajasthan. · Coimbatore, Tamil Nadu. ·J Assoc Physicians India · Pubmed #28782315.

ABSTRACT: -- No abstract --

17 Guideline [2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation]. 2017

Piepoli, Massimo F / Hoes, Arno W / Agewall, Stefan / Albus, Christian / Brotons, Carlos / Catapano, Alberico L / Cooney, Marie-Therese / Corrà, Ugo / Cosyns, Bernard / Deaton, Christi / Graham, Ian / Hall, Michael Stephen / Hobbs, F D Richard / Løchen, Maja-Lisa / Löllgen, Herbert / Marques-Vidal, Pedro / Perk, Joep / Prescott, Eva / Redon, Josep / Richter, Dimitrios J / Sattar, Naveed / Smulders, Yvo / Tiberi, Monica / van der Worp, H Bart / van Dis, Ineke / Verschuren, W M Monique. ·European Society of Cardiology (ESC). · International Society of Behavioural Medicine (ISBM). · WONCA Europe. · European Atherosclerosis Society (EAS). · International Diabetes Federation European Region (IDF Europe). · International Federation of Sport Medicine (FIMS). · European Society of Hypertension (ESH). · European Association for the Study of Diabetes (EASD). · European Stroke Organisation (ESO). · European Heart Network (EHN). ·G Ital Cardiol (Rome) · Pubmed #28714997.

ABSTRACT: -- No abstract --

18 Guideline Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. 2017

de Raaff, Christel A L / Gorter-Stam, Marguerite A W / de Vries, Nico / Sinha, Ashish C / Jaap Bonjer, H / Chung, Frances / Coblijn, Usha K / Dahan, Albert / van den Helder, Rick S / Hilgevoord, Antonius A J / Hillman, David R / Margarson, Michael P / Mattar, Samer G / Mulier, Jan P / Ravesloot, Madeline J L / Reiber, Beata M M / van Rijswijk, Anne-Sophie / Singh, Preet Mohinder / Steenhuis, Roos / Tenhagen, Mark / Vanderveken, Olivier M / Verbraecken, Johan / White, David P / van der Wielen, Nicole / van Wagensveld, Bart A. ·Department of Surgery, OLVG West, Amsterdam, the Netherlands. Electronic address: c.deraaff@olvg.nl. · Department of Surgery, VU Medical Center, Amsterdam, the Netherlands. · Department of Oral Kinesiology, ACTA, Amsterdam, the Netherlands; Department of Otorhinolaryngology and Head and Neck Surgery, Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Department of Otorhinolaryngology, OLVG West, Amsterdam, the Netherlands. · Department of Anesthesiology and Perioperative Medicine, Temple University, Philadelphia, PA, USA. · Department of Anesthesiology, University Health Network, University of Toronto, Toronto, Canada. · Department of Anesthesiology, LUMC, Leiden, the Netherlands. · Department of Surgery, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands. · Department of Clinical Neurophysiology, OLVG West, Amsterdam, the Netherlands. · Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Anaesthesia, Saint Richard's Hospital, Chichester, United Kingdom. · Department of Surgery, Oregon Health & Science University, Portland, Oregon, USA. · Department of Anesthesiology, AZ Sint Jan, Brugge, Belgium. · Department of Otorhinolaryngology, OLVG West, Amsterdam, the Netherlands. · Department of Surgery, Rode Kruis Ziekenhuis, Beverwijk, the Netherlands. · Department of Surgery, MC Slotervaart, Amsterdam, the Netherlands. · Department of Anesthesiology, All India Institute of Medical Sciences, New Delhi, India. · Medical Library, OLVG West, Amsterdam, the Netherlands. · Department of Otorhinolaryngology and Head and Neck Surgery, Translational Neurosciences Research Group, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Department of Pulmonary Medicine and Multidisciplinary Sleep Disorders Centre, Antwerp University Hospital and University of Antwerp, Edegem, Belgium. · Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Surgery, OLVG West, Amsterdam, the Netherlands. ·Surg Obes Relat Dis · Pubmed #28666588.

ABSTRACT: BACKGROUND: The frequency of metabolic and bariatric surgery (MBS) is increasing worldwide, with over 500,000 cases performed every year. Obstructive sleep apnea (OSA) is present in 35%-94% of MBS patients. Nevertheless, consensus regarding the perioperative management of OSA in MBS patients is not established. OBJECTIVES: To provide consensus based guidelines utilizing current literature and, when in the absence of supporting clinical data, expert opinion by organizing a consensus meeting of experts from relevant specialties. SETTING: The meeting was held in Amsterdam, the Netherlands. METHODS: A panel of 15 international experts identified 75 questions covering preoperative screening, treatment, postoperative monitoring, anesthetic care and follow-up. Six researchers reviewed the literature systematically. During this meeting, the "Amsterdam Delphi Method" was utilized including controlled acquisition of feedback, aggregation of responses and iteration. RESULTS: Recommendations or statements were provided for 58 questions. In the judgment of the experts, 17 questions provided no additional useful information and it was agreed to exclude them. With the exception of 3 recommendations (64%, 66%, and 66% respectively), consensus (>70%) was reached for 55 statements and recommendations. Several highlights: polysomnography is the gold standard for diagnosing OSA; continuous positive airway pressure is recommended for all patients with moderate and severe OSA; OSA patients should be continuously monitored with pulse oximetry in the early postoperative period; perioperative usage of sedatives and opioids should be minimized. CONCLUSION: This first international expert meeting provided 58 statements and recommendations for a clinical consensus guideline regarding the perioperative management of OSA patients undergoing MBS.

19 Guideline Recommended vitamin D levels in the general population. 2017

Varsavsky, Mariela / Rozas Moreno, Pedro / Becerra Fernández, Antonio / Luque Fernández, Inés / Quesada Gómez, José Manuel / Ávila Rubio, Verónica / García Martín, Antonia / Cortés Berdonces, María / Naf Cortés, Silvia / Romero Muñoz, Manuel / Reyes García, Rebeca / Jódar Gimeno, Esteban / Muñoz Torres, Manuel / Anonymous810976. ·Servicio de Endocrinología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina. · Servicio de Endocrinología, Hospital General Universitario de Ciudad Real, Ciudad Real, España. Electronic address: pedrorozasm@yahoo.es. · Unidad de Identidad de Género, Hospital Universitario Ramón y Cajal; Facultad de Medicina, Universidad de Alcalá, Madrid, España. · Servicio de Endocrinología y Nutrición, Hospital Virgen de la Salud, Toledo, España. · Unidad de Metabolismo Mineral, UGC Endocrinología y Nutrición; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía; RETICEF, Córdoba, España. · Unidad de Metabolismo Óseo, UGC Endocrinología y Nutrición, Complejo Hospitalario Universitario de Granada; RETICEF, Granada, España. · Servicio de Endocrinología y Nutrición, Hospital Ruber Juan Bravo, Madrid, España. · Hospital Universitari Joan XXIII, IISPV, Universitat Rovira i Virgili; CIBERDEM, Tarragona, España. · Unidad de Endocrinología y Nutrición, HGU Rafael Méndez, Lorca, Murcia, España. · Unidad de Endocrinología y Nutrición, Complejo Hospitalario Torrecárdenas; Servicio de Endocrinología, Clínica San Pedro, Almería, España. · Departamento de Endocrinología y Nutrición, Hospitales Universitarios Quirón Salud Madrid; Facultad de Ciencias de la Salud, Universidad Europea de Madrid, Madrid, España. ·Endocrinol Diabetes Nutr · Pubmed #28440763.

ABSTRACT: OBJECTIVE: To provide recommendations based on evidence on the management of vitaminD deficiency in the general population. PARTICIPANTS: Members of the Bone Metabolism Working Group of the Spanish Society of Endocrinology. METHODS: Recommendations were formulated using the GRADE system (Grading of Recommendations, Assessment, Development, and Evaluation) to describe both the strength of recommendations and the quality of evidence. A systematic search was made in MEDLINE (Pubmed) using the term VitaminD and the name of each issue. Papers in English and Spanish with publication date before 17 March 2016 were included. Recommendations were jointly discussed by the Working Group. CONCLUSIONS: This document summarizes the data about vitaminD deficiency in terms of prevalence, etiology, screening indications, adequate levels and effects of supplementation on bone and non-skeletal health outcomes.

20 Guideline Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. 2017

Styne, Dennis M / Arslanian, Silva A / Connor, Ellen L / Farooqi, Ismaa Sadaf / Murad, M Hassan / Silverstein, Janet H / Yanovski, Jack A. ·University of California Davis, Sacramento, California 95817. · University of Pittsburgh, Pittsburgh, Pennsylvania 15224. · University of Wisconsin, Madison, Wisconsin 53792. · University of Cambridge, Cambridge CB2 0QQ, United Kingdom. · Mayo Clinic, Rochester, Minnesota 55905. · University of Florida, Gainesville, Florida 32607; and. · National Institutes of Health, Bethesda, Maryland 20892. ·J Clin Endocrinol Metab · Pubmed #28359099.

ABSTRACT: Cosponsoring Associations: The European Society of Endocrinology and the Pediatric Endocrine Society. This guideline was funded by the Endocrine Society. Objective: To formulate clinical practice guidelines for the assessment, treatment, and prevention of pediatric obesity. Participants: The participants include an Endocrine Society-appointed Task Force of 6 experts, a methodologist, and a medical writer. Evidence: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation approach to describe the strength of recommendations and the quality of evidence. The Task Force commissioned 2 systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Endocrine Society committees and members and co-sponsoring organizations reviewed and commented on preliminary drafts of this guideline. Conclusion: Pediatric obesity remains an ongoing serious international health concern affecting ∼17% of US children and adolescents, threatening their adult health and longevity. Pediatric obesity has its basis in genetic susceptibilities influenced by a permissive environment starting in utero and extending through childhood and adolescence. Endocrine etiologies for obesity are rare and usually are accompanied by attenuated growth patterns. Pediatric comorbidities are common and long-term health complications often result; screening for comorbidities of obesity should be applied in a hierarchal, logical manner for early identification before more serious complications result. Genetic screening for rare syndromes is indicated only in the presence of specific historical or physical features. The psychological toll of pediatric obesity on the individual and family necessitates screening for mental health issues and counseling as indicated. The prevention of pediatric obesity by promoting healthful diet, activity, and environment should be a primary goal, as achieving effective, long-lasting results with lifestyle modification once obesity occurs is difficult. Although some behavioral and pharmacotherapy studies report modest success, additional research into accessible and effective methods for preventing and treating pediatric obesity is needed. The use of weight loss medications during childhood and adolescence should be restricted to clinical trials. Increasing evidence demonstrates the effectiveness of bariatric surgery in the most seriously affected mature teenagers who have failed lifestyle modification, but the use of surgery requires experienced teams with resources for long-term follow-up. Adolescents undergoing lifestyle therapy, medication regimens, or bariatric surgery for obesity will need cohesive planning to help them effectively transition to adult care, with continued necessary monitoring, support, and intervention. Transition programs for obesity are an uncharted area requiring further research for efficacy. Despite a significant increase in research on pediatric obesity since the initial publication of these guidelines 8 years ago, further study is needed of the genetic and biological factors that increase the risk of weight gain and influence the response to therapeutic interventions. Also needed are more studies to better understand the genetic and biological factors that cause an obese individual to manifest one comorbidity vs another or to be free of comorbidities. Furthermore, continued investigation into the most effective methods of preventing and treating obesity and into methods for changing environmental and economic factors that will lead to worldwide cultural changes in diet and activity should be priorities. Particular attention to determining ways to effect systemic changes in food environments and total daily mobility, as well as methods for sustaining healthy body mass index changes, is of importance.

21 Guideline White Paper AGA: POWER - Practice Guide on Obesity and Weight Management, Education, and Resources. 2017

Acosta, Andres / Streett, Sarah / Kroh, Mathew D / Cheskin, Lawrence J / Saunders, Katherine H / Kurian, Marina / Schofield, Marsha / Barlow, Sarah E / Aronne, Louis. ·Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. Electronic address: acostacardenas.andres@mayo.edu. · Inflammatory Bowel Disease, Stanford University School of Medicine, Stanford, California. · Department of Surgical Endoscopy, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. · Johns Hopkins Weight Management Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. · Comprehensive Weight Control Center, Weill Cornell Medical College, New York, New York and representative of The Obesity Society. · Department of Minimally Invasive Surgery, New York University, New York, New York. · Nutrition Services Coverage, Academy of Nutrition and Dietetics, Chicago, Illinois. · Baylor College of Medicine and Center for Childhood Obesity, Texas Children's Hospital, Houston, Texas and representative of North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. ·Clin Gastroenterol Hepatol · Pubmed #28242319.

ABSTRACT: The epidemic of obesity continues at alarming rates, with a high burden to our economy and society. The American Gastroenterological Association understands the importance of embracing obesity as a chronic, relapsing disease and supports a multidisciplinary approach to the management of obesity. Because gastrointestinal disorders resulting from obesity are more frequent and often present sooner than type 2 diabetes mellitus and cardiovascular disease, gastroenterologists have an opportunity to address obesity and provide an effective therapy early. Patients who are overweight or obese already fill gastroenterology clinics with gastroesophageal reflux disease and its associated risks of Barrett's esophagus and esophageal cancer, gallstone disease, nonalcoholic fatty liver disease/nonalcoholic steatohepatitis, and colon cancer. Obesity is a major modifiable cause of diseases of the digestive tract that frequently goes unaddressed. As internists, specialists in digestive disorders, and endoscopists, gastroenterologists are in a unique position to play an important role in the multidisciplinary treatment of obesity. This American Gastroenterological Association paper was developed with content contribution from Society of American Gastrointestinal and Endoscopic Surgeons, The Obesity Society, Academy of Nutrition and Dietetics, and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, endorsed with input by American Society for Gastrointestinal Endoscopy, American Society for Metabolic and Bariatric Surgery, American Association for the Study of Liver Diseases, and Obesity Medicine Association, and describes POWER: Practice Guide on Obesity and Weight Management, Education and Resources. Its objective is to provide physicians with a comprehensive, multidisciplinary process to guide and personalize innovative obesity care for safe and effective weight management.

22 Guideline Combined hormonal contraception and the risk of venous thromboembolism: a guideline. 2017

Anonymous330886 / Anonymous340886. ·American Society for Reproductive Medicine, Birmingham, Alabama. ·Fertil Steril · Pubmed #27793376.

ABSTRACT: While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

23 Guideline ESPEN guidelines on definitions and terminology of clinical nutrition. 2017

Cederholm, T / Barazzoni, R / Austin, P / Ballmer, P / Biolo, G / Bischoff, S C / Compher, C / Correia, I / Higashiguchi, T / Holst, M / Jensen, G L / Malone, A / Muscaritoli, M / Nyulasi, I / Pirlich, M / Rothenberg, E / Schindler, K / Schneider, S M / de van der Schueren, M A E / Sieber, C / Valentini, L / Yu, J C / Van Gossum, A / Singer, P. ·Departments of Geriatric Medicine, Uppsala University Hospital and Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden. Electronic address: tommy.cederholm@pubcare.uu.se. · Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. Electronic address: barazzon@units.it. · Pharmacy Department, Oxford University Hospitals NHS Foundation Trust, United Kingdom; Pharmacy Department, University Hospital Southampton NHS Foundation Trust, United Kingdom. Electronic address: peter.austin@uhs.nhs.uk. · Department of Medicine, Kantonsspital Winterthur, Winterthur, Switzerland. Electronic address: peter.ballmer@ksw.ch. · Institute of Clinical Medicine, University of Trieste, Trieste, Italy. Electronic address: biolo@units.it. · Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany. Electronic address: bischoff.stephan@uni-hohenheim.de. · School of Nursing, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: compherc@nursing.upenn.edu. · Department of Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil. Electronic address: isabel_correia@uol.com.br. · Department of Surgery and Palliative Medicine, Fujita Health University, School of Medicine, Toyoake, Japan. Electronic address: t-gucci30219@herb.ocn.ne.jp. · Center for Nutrition and Bowel Disease, Department of Gastroenterology, Aalborg University Hospital, Aalborg, Denmark. Electronic address: mette.holst@rn.dk. · The Dean's Office and Department of Medicine, The University of Vermont College of Medicine, Burlington, VT, USA. Electronic address: gordon.jensen@med.uvm.edu. · Pharmacy Department, Mount Carmel West Hospital, Columbus, OH, USA. Electronic address: ainsleym@nutritioncare.org. · Department of Clinical Medicine, Sapienza University of Rome, Italy. Electronic address: maurizio.muscaritoli@uniroma1.it. · Nutrition and Dietetics, Alfred Health, Melbourne, Australia. Electronic address: i.nyulasi@alfred.org.au. · Department of Internal Medicine, Elisabeth Protestant Hospital, Berlin, Germany. Electronic address: matthias.pirlich@pgdiakonie.de. · Department of Food and Meal Science, Kristianstad University, Kristianstad, Sweden. Electronic address: elisabet.rothenberg@vgregion.se. · Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University Vienna, Vienna, Austria. Electronic address: karin.schindler@meduniwien.ac.at. · Department of Gastroenterology and Clinical Nutrition, Archet Hospital, University of Nice Sophia Antipolis, Nice, France. Electronic address: stephane.schneider@unice.fr. · Department of Nutrition and Dietetics, Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands; Department of Nutrition, Sports and Health, Faculty of Health and Social Studies, HAN University of Applied Sciences, Nijmegen, The Netherlands. Electronic address: m.devanderschueren@vumc.nl. · Institute for Biomedicine of Ageing, Friedrich-Alexander University Erlangen-Nürnberg, Hospital St. John of Lord, Regensburg, Germany. Electronic address: cornel.sieber@fau.de. · Department of Agriculture and Food Sciences, Section of Dietetics, University of Applied Sciences, Neubrandenburg, Germany. Electronic address: valentini@hs-nb.de. · Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address: yu-jch@163.com. · Department of Gastroenterology, Clinic of Intestinal Diseases and Nutritional Support, Hopital Erasme, Free University of Brussels, Brussels, Belgium. Electronic address: Andre.VanGossum@erasme.ulb.ac.be. · Department of Critical Care, Institute for Nutrition Research, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Petah Tikva 49100 Israel. Electronic address: pierre.singer@gmail.com. ·Clin Nutr · Pubmed #27642056.

ABSTRACT: BACKGROUND: A lack of agreement on definitions and terminology used for nutrition-related concepts and procedures limits the development of clinical nutrition practice and research. OBJECTIVE: This initiative aimed to reach a consensus for terminology for core nutritional concepts and procedures. METHODS: The European Society of Clinical Nutrition and Metabolism (ESPEN) appointed a consensus group of clinical scientists to perform a modified Delphi process that encompassed e-mail communication, face-to-face meetings, in-group ballots and an electronic ESPEN membership Delphi round. RESULTS: Five key areas related to clinical nutrition were identified: concepts; procedures; organisation; delivery; and products. One core concept of clinical nutrition is malnutrition/undernutrition, which includes disease-related malnutrition (DRM) with (eq. cachexia) and without inflammation, and malnutrition/undernutrition without disease, e.g. hunger-related malnutrition. Over-nutrition (overweight and obesity) is another core concept. Sarcopenia and frailty were agreed to be separate conditions often associated with malnutrition. Examples of nutritional procedures identified include screening for subjects at nutritional risk followed by a complete nutritional assessment. Hospital and care facility catering are the basic organizational forms for providing nutrition. Oral nutritional supplementation is the preferred way of nutrition therapy but if inadequate then other forms of medical nutrition therapy, i.e. enteral tube feeding and parenteral (intravenous) nutrition, becomes the major way of nutrient delivery. CONCLUSION: An agreement of basic nutritional terminology to be used in clinical practice, research, and the ESPEN guideline developments has been established. This terminology consensus may help to support future global consensus efforts and updates of classification systems such as the International Classification of Disease (ICD). The continuous growth of knowledge in all areas addressed in this statement will provide the foundation for future revisions.

24 Guideline The rehabilitation of children and adolescents with severe or medically complicated obesity: an ISPED expert opinion document. 2017

Grugni, Graziano / Licenziati, Maria Rosaria / Valerio, Giuliana / Crinò, Antonino / Maffeis, Claudio / Tanas, Rita / Morino, Giuseppe Stefano / Anonymous2761055. ·Division of Auxology, Italian Auxological Institute, Verbania, Italy. · Department of Pediatrics, AORN Santobono-Pausilipon, Naples, Italy. mrlicenziati@gmail.com. · Department of Movement Sciences and Wellness, Parthenope University, Naples, Italy. · Autoimmune Endocrine Diseases Unit Bambino Gesù Hospital, Research Hospital Palidoro, Rome, Italy. · Pediatric Diabetes and Metabolic Disorders Unit, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy. · Pediatric Unit, Azienda Ospedaliera Universitaria, Ferrara, Italy. · Nutrition Education Unit, Bambino Gesù Hospital, San Paolo Hospital, Rome, Italy. ·Eat Weight Disord · Pubmed #27585923.

ABSTRACT: Severe/medically complicated obesity in childhood, and particularly in adolescence, is a real disability that requires an intensive and continuous approach which should follow the procedures and schedule of rehabilitation medicine. Given the lack of a specific document focusing on children and adolescents, the Childhood Obesity Study Group set out to explore the available evidence for the treatment of severe or medically complicated obesity and to set standards tailored to the specific context of the Italian Health Service. Through a series of meetings and electronic communications, the writing committee (selected from members of the Study Group) selected the key issues, explored the literature and produced a draft document which was submitted to the other experts until the final synthesis was approved by the group. In brief, the following issues were involved: (1) definition and epidemiology; (2) identification of common goals designed to regain functional competence and limit the progression of metabolic and psychological complications; (3) a multi-professional team approach; (4) the care setting. This paper is an expert opinion document on the rehabilitation of severe and medically complicated obesity in children and adolescents produced by experts belonging to the Childhood Obesity Study Group of the Italian Society for Pediatric Endocrinology and Diabetology (ISPED).

25 Guideline Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology. 2017

Bellizzi, Vincenzo / Conte, Giuseppe / Borrelli, Silvio / Cupisti, Adamasco / De Nicola, Luca / Di Iorio, Biagio R / Cabiddu, Gianfranca / Mandreoli, Marcora / Paoletti, Ernesto / Piccoli, Giorgina B / Quintaliani, Giuseppe / Ravera, Maura / Santoro, Domenico / Torraca, Serena / Minutolo, Roberto / Anonymous5020879. ·Division of Nephrology, Dialysis and Transplantation, Nephrology Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Via San Leonardo, 84131, Salerno, Italy. vincenzo.bellizzi@tin.it. · Nephrology Division, Second University of Naples, Naples, Italy. · Dept. of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. · Nephrology Unit, Landolfi Hospital, Solofra, AV, Italy. · Nephrology Division, Brotzu Hospital, Cagliari, Italy. · Nephrology and Dialysis Unit, Ospedale S. Maria della Scaletta, Imola, BO, Italy. · Nephrology Unit, University of Genoa and IRCCS A.O.U. San Martino IST, Genoa, Italy. · Dept. of Clinical and Biological Sciences, University of Torino, Torino, Italy. · Nephrologie, CH Le Mans, Le Mans, France. · O. U. Nephrology, Dialysis and Transplantation, Santa Maria della Misericordia Hospital, Perugia, Italy. · Dept. of Internal Medicine, University of Messina, Messina, Italy. · Division of Nephrology, Dialysis and Transplantation, Nephrology Unit, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Via San Leonardo, 84131, Salerno, Italy. ·J Nephrol · Pubmed #27568307.

ABSTRACT: This position paper of the study group "Conservative treatment of Chronic Kidney Disease-CKD" of the Italian Society of Nephrology addresses major practical, unresolved, issues related to the conservative treatment of chronic renal disease. Specifically, controversial topics from everyday clinical nephrology practice which cannot find a clear, definitive answer in the current literature or in nephrology guidelines are discussed. The paper reports the point of view of the study group. Concise and practical advice is given on several common issues: renal biopsy in diabetes; dual blockade of the renin-angiotensin-aldosterone system (RAAS); management of iron deficiency; low protein diet; dietary salt intake; bicarbonate supplementation; treatment of obesity; the choice of conservative therapy vs. dialysis. For each topic synthetic statements, guideline-style, are reported.